Moderna stock has reached day 5 of a consecutive winning streak, with total gains during this time reaching a 13% return.

Company reports Q3 2025 AUCATZYL® net product revenue of $21.1 million and deferred revenue of $7.6 million; 60 authorized treatment centers ...

Reports third quarter revenue of $1.0 billion, GAAP net loss of $(0.2) billion and GAAP EPS of $(0.51) Narrows 2025 projected ...

The second edition of the film festival promoted by TAP Air Portugal on board its aircraft announced its winners yesterday, ...

The second edition of the film festival promoted by TAP Air Portugal on board its aircraft announced its winners on World ...

Flick Truck Accident Law, is pleased to announce its membership in the Commercial Vehicle Safety Alliance (CVSA). KANSAS CITY, Mo., Nov. 6, 2025 / PRZen / Flick Truck Accident Law, a law firm focused ...

Heidrick & Struggles will lead a search for a new CFO as the company seeks to execute on a “return to growth” plan aimed at ...

Q3 2025 Earnings Call Transcript November 6, 2025 Moderna, Inc. beats earnings expectations. Reported EPS is $-0.51282, ...

Biotechnology company Moderna (NASDAQ:MRNA) reported revenue ahead of Wall Streets expectations in Q3 CY2025, but sales fell by 45.4% year on year to $1.02 billion. On the other hand, the company’s ...

Los Angeles, California – November 03, 2025 – PRESSADVANTAGE – Time Off Editing has announced the launch of a dedicated Real ...

Get the latest insights from Moderna's Q3 2025 earnings call: revenue guidance updates, cost reduction highlights, and pipeline progress.

Moderna MRNA incurred a loss of 51 cents per share in the third quarter of 2025, narrower than the Zacks Consensus Estimate ...